TY - JOUR
T1 - Association of Lipids, Lipoproteins, and Apolipoproteins with Stroke Subtypes in an International Case Control Study (INTERSTROKE)
AU - INTERSTROKE investigators
AU - O’donnell, Martin J.
AU - McQueen, Matthew
AU - Sniderman, Allan
AU - Pare, Guillaume
AU - Wang, Xingyu
AU - Hankey, Graeme J.
AU - Rangarajan, Sumathy
AU - Chin, Siu Lim
AU - Rao-Melacini, Purnima
AU - Ferguson, John
AU - Xavier, Denis
AU - Lisheng, Liu
AU - Zhang, Hongye
AU - Pais, Prem
AU - Lopez-Jaramillo, Patricio
AU - Damasceno, Albertino
AU - Langhorne, Peter
AU - Rosengren, Annika
AU - Dans, Antonio L.
AU - Elsayed, Ahmed
AU - Avezum, Alvaro
AU - Mondo, Charles
AU - Judge, Conor
AU - Diener, Hans Christoph
AU - Ryglewicz, Danuta
AU - Czlonkowska, Anna
AU - Pogosova, Nana
AU - Weimar, Christian
AU - Iqbal, Romana
AU - Diaz, Rafael
AU - Yusoff, Khalid
AU - Yusufali, Afzalhussein
AU - Oguz, Aytekin
AU - Penaherrera, Ernesto
AU - Lanas, Fernando
AU - Ogah, Okechukwu S.
AU - Ogunniyi, Adesola
AU - Iversen, Helle K.
AU - Malaga, German
AU - Rumboldt, Zvonko
AU - Oveisgharan, Shahram
AU - Hussain, Fawaz Al
AU - Nilanont, Yongchai
AU - Yusuf, Salim
N1 - Publisher Copyright:
© 2022 Korean Stroke Society.
PY - 2022/5
Y1 - 2022/5
N2 - Background and Purpose The association of dyslipidemia with stroke has been inconsistent, which may be due to differing associations within etiological stroke subtypes. We sought to determine the association of lipoproteins and apolipoproteins within stroke subtypes. Methods Standardized incident case-control STROKE study in 32 countries. Cases were patients with acute hospitalized first stroke, and matched by age, sex and site to controls. Concentrations of total cholesterol, high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), apolipoprotein A1 (apoA1), and apoB were measured. Non-HDL-C was calculated. We estimated multivariable odds ratio (OR) and population attributable risk percentage (PAR%). Outcome measures were all stroke, ischemic stroke (and subtypes), and intracerebral hemorrhage (ICH). Results Our analysis included 11,898 matched case-control pairs; 77.3% with ischemic stroke and 22.7% with ICH. Increasing apoB (OR, 1.10; 95% confidence interval [CI], 1.06 to 1.14 per standard deviation [SD]) and LDL-C (OR, 1.06; 95% CI, 1.02 to 1.10 per SD) were associated with an increase in risk of ischemic stroke, but a reduced risk of ICH. Increased apoB was significantly associated with large vessel stroke (PAR 13.4%; 95% CI, 5.6 to 28.4) and stroke of undetermined cause. Higher HDL-C (OR, 0.75; 95% CI, 0.72 to 0.78 per SD) and apoA1 (OR, 0.63; 95% CI, 0.61 to 0.66 per SD) were associated with ischemic stroke (and subtypes). While increasing HDL-C was associated with an increased risk of ICH (OR, 1.20; 95% CI, 1.14 to 1.27 per SD), apoA1 was associated with a reduced risk (OR, 0.80; 95% CI, 0.75 to 0.85 per SD). ApoB/A1 (OR, 1.38; 95% CI, 1.32 to 1.44 per SD) had a stronger magnitude of association than the ratio of LDL-C/HDL-C (OR, 1.26; 95% CI, 1.21 to 1.31 per SD) with ischemic stroke (P<0.0001). Conclusions The pattern and magnitude of association of lipoproteins and apolipoproteins with stroke varies by etiological stroke subtype. While the directions of association for LDL, HDL, and apoB were opposing for ischemic stroke and ICH, apoA1 was associated with a reduction in both ischemic stroke and ICH. The ratio of apoB/A1 was the best lipid predictor of ischemic stroke risk.
AB - Background and Purpose The association of dyslipidemia with stroke has been inconsistent, which may be due to differing associations within etiological stroke subtypes. We sought to determine the association of lipoproteins and apolipoproteins within stroke subtypes. Methods Standardized incident case-control STROKE study in 32 countries. Cases were patients with acute hospitalized first stroke, and matched by age, sex and site to controls. Concentrations of total cholesterol, high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), apolipoprotein A1 (apoA1), and apoB were measured. Non-HDL-C was calculated. We estimated multivariable odds ratio (OR) and population attributable risk percentage (PAR%). Outcome measures were all stroke, ischemic stroke (and subtypes), and intracerebral hemorrhage (ICH). Results Our analysis included 11,898 matched case-control pairs; 77.3% with ischemic stroke and 22.7% with ICH. Increasing apoB (OR, 1.10; 95% confidence interval [CI], 1.06 to 1.14 per standard deviation [SD]) and LDL-C (OR, 1.06; 95% CI, 1.02 to 1.10 per SD) were associated with an increase in risk of ischemic stroke, but a reduced risk of ICH. Increased apoB was significantly associated with large vessel stroke (PAR 13.4%; 95% CI, 5.6 to 28.4) and stroke of undetermined cause. Higher HDL-C (OR, 0.75; 95% CI, 0.72 to 0.78 per SD) and apoA1 (OR, 0.63; 95% CI, 0.61 to 0.66 per SD) were associated with ischemic stroke (and subtypes). While increasing HDL-C was associated with an increased risk of ICH (OR, 1.20; 95% CI, 1.14 to 1.27 per SD), apoA1 was associated with a reduced risk (OR, 0.80; 95% CI, 0.75 to 0.85 per SD). ApoB/A1 (OR, 1.38; 95% CI, 1.32 to 1.44 per SD) had a stronger magnitude of association than the ratio of LDL-C/HDL-C (OR, 1.26; 95% CI, 1.21 to 1.31 per SD) with ischemic stroke (P<0.0001). Conclusions The pattern and magnitude of association of lipoproteins and apolipoproteins with stroke varies by etiological stroke subtype. While the directions of association for LDL, HDL, and apoB were opposing for ischemic stroke and ICH, apoA1 was associated with a reduction in both ischemic stroke and ICH. The ratio of apoB/A1 was the best lipid predictor of ischemic stroke risk.
KW - Apolipoproteins
KW - Case-control
KW - Dyslipidemia
KW - Lipoproteins
KW - Risk factor
KW - Stroke
UR - http://www.scopus.com/inward/record.url?scp=85131863063&partnerID=8YFLogxK
U2 - 10.5853/jos.2021.02152
DO - 10.5853/jos.2021.02152
M3 - Article
AN - SCOPUS:85131863063
SN - 2287-6391
VL - 24
SP - 224
EP - 235
JO - Journal of Stroke
JF - Journal of Stroke
IS - 2
ER -